Tweet
Virus Res
. 2021 Apr 2;198409.
doi: 10.1016/j.virusres.2021.198409. Online ahead of print.
Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus
Zenglei Hu 1 , Jiangyan Zhao 2 , Lei Shi 2 , Jiao Hu 3 , Shunlin Hu 3 , Xiufan Liu 4
Affiliations
- PMID: 33819520
- DOI: 10.1016/j.virusres.2021.198409
Abstract
H7N9 avian influenza vaccines induce high levels of non-neutralizing (nonNeu) antibodies against the haemagglutinin (HA). However, the antigenic epitopes underlying this particular antibody response are still undefined. In this study, a panel of 13 monoclonal antibodies (mAbs) against the HA protein of H7N9 virus was generated and 12 of them had no hemagglutination inhibition and virus neutralizing activities. One linear epitope in the stalk (373-TAA-375) recognized by three mAbs and one conformational epitope in the head (220Q-225S-227 G) targeted by one mAb were identified using peptide-based enzyme-linked immunosorbent assay (ELISA) and biopanning of phage display random peptide library. In addition, competition ELISA revealed that the mAb targeting the head epitope strongly inhibited HA-binding of chicken nonNeu anti-H7N9 sera, whereas lower inhibition was observed for chicken neutralizing antisera, indicating the immunodominance of this epitope in the elicitation of nonNeu antibodies. Moreover, the stalk epitope is conserved among the H1-H17 subtypes and the mAb recognizing this epitope exhibited cross-reactivity with different subtypes. In conclusion, two novel nonNeu epitopes in H7N9 HA were identified, and an epitope in the head was identified as an immunodominant epitope underlying the induction of nonNeu H7N9 antibodies. Our results add new knowledge to the molecular basis for antibody immunity against H7N9 vaccines and provide useful implications for vaccine design and modification.
Keywords: H7N9 avian influenza virus; antibody immunity; epitope; haemagglutinin; non-neutralizing antibody; vaccine.